Press release
Cyber Intelligence 4U, Meratas and ISA Plus Launch Incentive-Aligned Cyber Education Fund
Cyber Intelligence 4U, Inc. (CIU) is proud to announce an innovative incentive-aligned program for cybersecurity professionals to finance their continuing education using Income Sharing Agreements (ISAs) in partnership with ISA Plus and Meratas.Cyber Intelligence 4U (CIU) is a cybersecurity workforce acceleration partner that uses hands-on training to educate and provide real world, clinical experience. CIU is the global leader in cybersecurity education with over 4,000 graduates of their programs since 2018. Their partnership with ISA Plus and Meratas will help students further their careers in cybersecurity using an innovative incentive-aligned tuition model.
“Education should be accessible to everyone, and ISAs help make that possible. This partnership will help students graduate from CIU’s cybersecurity programs with funding available from ISA Plus and consumer friendly ISA management from the Meratas Platform” said Prof. Ariel Evans, CEO of CIU.
Income Share Agreements (or ISAs) are a favored method for financing continuing education because they remove the upfront financial hurdles typically associated with traditional educational programs. With an ISA, payments are correlated to earned income, meaning monthly payments will rise or fall based on when you’re earning more or less, but the percentage paid will always be the same. As explained by Darius Goldman, CEO of Meratas: “With income correlated payments, students receive automatic payment protection when they’re unemployed or underemployed. This down-side protection is a key benefit of ISAs. Interestingly, in the case of CIU, most of their program graduates are high earners, so it was crucial that we designed a way to mitigate the risk of potential overpayment. Working with the team at CIU, Meratas came up with a revolutionary design, which protects high earners in two distinct, but related, ways.”
Goldman continued: “First, CIU is using a 1x incremental payment cap, meaning, a student can pay off their ISA at the same cost of tuition at any time within one year of graduation. This is the functional equivalent of an interest-free loan and is practically unheard of in higher education. Second, to ensure high earners are further protected, CIU is voluntarily limiting their monthly payments to be the lesser of 10% of income or $625/month. This means that anyone earning over $75,000 annually (which is very common in cybersecurity), will only pay $625/month, despite having a 10% income share. In speaking with hundreds of consumers, we created this monthly payment cap as yet one more way to protect high-earners from oversharing, while still affording them the downside protections available from the ISA structure.”
CIU’s inclusion of both incremental payment caps and monthly payment limits is testament to their outcomes and conviction to incentive-aligned tuition models.
Cyber Intelligence 4U, Inc.
555 Madison Ave, 5th Floor, New York NY 10022
info@cyberintelu.com
Press contact: Julie@cyberintelu.com
About Meratas
Meratas Inc., provides a turn-key software solution to originate and service ISAs. The Meratas platform handles everything from student applications and underwriting through income verification, payment collections & performance reporting, all with unparalleled emphasis on provider and consumer benefits. Using a platform approach, Meratas seeks to democratize access to continued education by hosting a marketplace where students can easily access ISA resources, research, and apply to schools offering ISA tuition programs. In turn, employers can access the same marketplace to signal where jobs are needed, directly recruiting from the schools filling these skills gaps. For more information, please visit https://www.meratas.com/
About Cyber Intelligence 4U, Inc.
Cyber Intelligence 4U (CIU)is a workforce acceleration partner that uses hands-on training to not only educate but also provide real world experience. CIU partners with the world’s leading corporations and universities to help bridge the cybersecurity skills gaps. CIU programs are created by cybersecurity professionals (CISOs, Forensic Experts, DPOs, Risk Managers and Auditors, etc.) with boots on the ground expertise that cannot be replicated in an purely academic setting. CIU programs are market driven content created by former NSA elite, CISOs, DPOs, and top-flight executives, which leads to their industry topping a 98% satisfaction rating from students. CIU provides real experience, leading to real jobs. CIU caters to diverse needs by providing both by learning in person or online that is self-paced. CIU has offices in New York, Israel, London, and Germany. For more information, please visit https://cyberintelu.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cyber Intelligence 4U, Meratas and ISA Plus Launch Incentive-Aligned Cyber Education Fund here
News-ID: 2281998 • Views: …
More Releases for CIU
Chronic Idiopathic Urticaria Market Insights and Future Outlook
Chronic idiopathic urticaria (CIU), also known as chronic spontaneous urticaria (CSU), is a persistent skin condition characterized by recurrent hives and itching lasting six weeks or longer without an identifiable trigger. While not life-threatening, the disease has a major impact on patients' quality of life due to discomfort, sleep disturbances, and psychological distress.
Conventional antihistamines and corticosteroids remain the mainstay of treatment, but biologics such as omalizumab (Xolair) and investigational therapies…
Chronic Idiopathic Urticaria Clinical and Non-Clinical Studies, Key Companies, T …
Chronic Idiopathic Urticaria Pipeline constitutes 15+ key companies continuously working towards developing 20+ Chronic Idiopathic Urticaria treatment therapies, analyzes DelveInsight.
Chronic Idiopathic Urticaria Overview:
**Chronic Urticaria (CU)** is defined as **recurrent wheals** occurring on most days for **at least six weeks**. It is classified into **chronic spontaneous urticaria (CSU)** and **chronic inducible urticaria (CIndU)**. While **CSU has no identifiable cause**, **CIndU** is triggered by **specific physical stimuli**.
Most cases of **CU**…
Chronic Idiopathic Urticaria (CIU) Treatment Market Exploring Key CAGR 8% Trends …
According to a new report published by CoherentMI The Chronic Idiopathic Urticaria (CIU) treatment market is estimated to be valued at USD 15.12 Bn in 2024 and is expected to reach USD 25.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8% from 2024 to 2031.
The Global Chronic Idiopathic Urticaria (CIU) Treatment Market has recently been analyzed and explored by CoherentMI in their latest market…
Chronic Idiopathic Urticaria (CIU) Treatment Market Impact of Targeted Therapies …
According to a new report published by CoherentMI The Chronic Idiopathic Urticaria (CIU) treatment market is estimated to be valued at USD 15.12 Bn in 2024 and is expected to reach USD 25.91 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8% from 2024 to 2031
The Latest research report on the Chronic Idiopathic Urticaria (CIU) Treatment Market 2024 provides a comprehensive analysis of the current market…
Chronic Idiopathic Urticaria (CIU) Treatment Market Sector Analysis, Market Tren …
A new Report by CoherentMI Market Reports, titled "Pneumonia, Pneumococcal Therapeutic Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Pneumonia, Pneumococcal Therapeutic market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The Chronic Idiopathic Urticaria (CIU) treatment market is estimated to be valued at USD 15.12 Bn in 2024 and…
Thymic Carcinoma Drugs Market Industry Growth Analysis, Market Size, and Share R …
A new Report by CoherentMI Market Reports, titled "Chronic Idiopathic Urticaria (CIU) Treatment Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Chronic Idiopathic Urticaria (CIU) Treatment market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The thymic carcinoma drugs market is estimated to be valued at USD 380 Mn in…